IN2013CH04511A - - Google Patents
Info
- Publication number
- IN2013CH04511A IN2013CH04511A IN4511CH2013A IN2013CH04511A IN 2013CH04511 A IN2013CH04511 A IN 2013CH04511A IN 4511CH2013 A IN4511CH2013 A IN 4511CH2013A IN 2013CH04511 A IN2013CH04511 A IN 2013CH04511A
- Authority
- IN
- India
- Prior art keywords
- preparation
- present
- provides
- ragorafenib
- crystalline solid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN4511CH2013 IN2013CH04511A (enrdf_load_stackoverflow) | 2013-10-04 | 2014-09-29 | |
| PCT/IN2014/000630 WO2015049698A2 (en) | 2013-10-04 | 2014-09-29 | Process for regorafenib |
| US15/026,694 US9518020B2 (en) | 2013-10-04 | 2014-09-29 | Process for Regorafenib |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN4511CH2013 IN2013CH04511A (enrdf_load_stackoverflow) | 2013-10-04 | 2014-09-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2013CH04511A true IN2013CH04511A (enrdf_load_stackoverflow) | 2015-04-10 |
Family
ID=52779244
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN4511CH2013 IN2013CH04511A (enrdf_load_stackoverflow) | 2013-10-04 | 2014-09-29 |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US9518020B2 (enrdf_load_stackoverflow) |
| IN (1) | IN2013CH04511A (enrdf_load_stackoverflow) |
| WO (1) | WO2015049698A2 (enrdf_load_stackoverflow) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105330600B (zh) * | 2015-11-30 | 2018-05-22 | 山东罗欣药业集团股份有限公司 | 一种瑞戈菲尼的制备方法 |
| AU2016387566A1 (en) * | 2016-01-18 | 2018-08-09 | Natco Pharma Ltd | An improved process for the preparation of Regorafenib |
| CN108558747A (zh) * | 2018-03-31 | 2018-09-21 | 山东罗欣药业集团恒欣药业有限公司 | 一种瑞戈非尼的制备方法 |
| CN108440403A (zh) * | 2018-03-31 | 2018-08-24 | 山东罗欣药业集团恒欣药业有限公司 | 一种瑞戈非尼的制备方法 |
| CN114315710B (zh) * | 2022-01-07 | 2024-04-26 | 江苏豪森药业集团有限公司 | 一种制备或纯化瑞戈非尼的方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY191349A (en) * | 2004-08-27 | 2022-06-17 | Bayer Pharmaceuticals Corp | New pharmaceutical compositions for the treatment of hyper-proliferative disorders |
| AR062927A1 (es) * | 2006-10-11 | 2008-12-17 | Bayer Healthcare Ag | 4- [4-( [ [ 4- cloro-3-( trifluorometil) fenil) carbamoil] amino] -3- fluorofenoxi) -n- metilpiridin-2- carboxamida monohidratada |
| US20120225057A1 (en) * | 2006-10-11 | 2012-09-06 | Deciphera Pharmaceuticals, Llc | Methods and compositions for the treatment of myeloproliferative diseases and other proliferative diseases |
| WO2011080749A1 (en) * | 2009-12-29 | 2011-07-07 | Hetero Research Foundation | Process for purification of ziprasidone |
| AR081060A1 (es) * | 2010-04-15 | 2012-06-06 | Bayer Schering Pharma Ag | Procedimiento para preparar 4-{4-[({[4-cloro-3-(trifluorometil)fenil]amino}carbonil)amino]-3-fluorofenoxi}-n-metilpiridin-2-carboxamida |
-
2014
- 2014-09-29 US US15/026,694 patent/US9518020B2/en active Active
- 2014-09-29 WO PCT/IN2014/000630 patent/WO2015049698A2/en active Application Filing
- 2014-09-29 IN IN4511CH2013 patent/IN2013CH04511A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2015049698A3 (en) | 2015-08-13 |
| US9518020B2 (en) | 2016-12-13 |
| US20160251313A1 (en) | 2016-09-01 |
| WO2015049698A2 (en) | 2015-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ726859A (en) | Synthesis of polycyclic-carbamoylpyridone compounds | |
| IL252089B (en) | 2-amino-6-(difluoromethyl)-5,5,-difluoro-6-phenyl-6,5,4,3-tetrahydropyridines as BACE1 inhibitors | |
| IN2013MU00646A (enrdf_load_stackoverflow) | ||
| PH12017500833A1 (en) | Synthesis of copanlisib and its dihydrochloride salt | |
| GB201311938D0 (en) | Process for preparing clomazone, a novel form and use of the same | |
| MY183123A (en) | Synthesis of copanlisib and its di hydrochloride salt | |
| IN2013MU00848A (enrdf_load_stackoverflow) | ||
| IN2013CH04511A (enrdf_load_stackoverflow) | ||
| IN2014MU00675A (enrdf_load_stackoverflow) | ||
| EP2948441A4 (en) | PROCESS FOR PREPARATION OF 1- (4- (4- (3,4-DICHLOR-2-FLUORO-PHENYL AMINO) -7-METHOXYCHINAZOLINE-6-YLOXY) PIPERIDIN-1-YL) PROP-2-EN-1-ON | |
| NZ720106A (en) | A process for the preparation of regadenoson | |
| IN2013MU01113A (enrdf_load_stackoverflow) | ||
| IL265893A (en) | Crystal forms of 4-(2-((r1(2r,-2-hydroxycyclohexylamino)benzothiazol-6-yloxy)-n-methylpicolinamide | |
| IL239987A0 (en) | A process for the production of a pyridazinone compound and its intermediate production | |
| SI3154967T1 (sl) | Postopki za pripravo alkiliranih arilpiperazinskih in alkiliranih arilpiperidinskih spojin, ki vključujejo nove intermediate | |
| PL2978322T3 (pl) | Proces wytwarzania stabilnych emulsji | |
| MX369174B (es) | Proceso para la preparación de un compuesto. | |
| IN2014CH00444A (enrdf_load_stackoverflow) | ||
| WO2014170909A3 (en) | Process for pomalidomide | |
| IL238829B (en) | Process for the preparation of 4-(cyclopropylmethoxy-3,5)-n-(dichloro-1-oxido-4-pyridyl)-5-methoxypyridine-2-carboxamide | |
| IN2013MU01524A (enrdf_load_stackoverflow) | ||
| MX2018001296A (es) | Proceso para la sintesis de ravidasvir. | |
| MX2016001100A (es) | Proceso mejorado para preparar la forma cristalina iv del posaconazol. | |
| IN2013MU03466A (enrdf_load_stackoverflow) | ||
| IN2013CH05395A (enrdf_load_stackoverflow) |